Patent Applications published on Jun 22, 2023 - page 4

#901 ✅ Patent 12,102,599 granted on 2024-10-01
US20230190582A1
Human necessities

Pressurized gas powered liquid transfer device and system

#902 ✅ Patent 12,303,467 granted on 2025-05-20
US20230190583A1
Human necessities

Tablet receptacle and drug dispensing device

#903
US20230190584A1
Human necessities

SMART TEETHING APPARATUS

#904 ✅ Patent 12,186,414 granted on 2025-01-07
US20230190585A1
Human necessities

Composition and method for endodontic debridement

#905
US20230190586A1
Human necessities

DENTAL FORMULATION FOR THE TREATMENT OF TOOTH SENSITIVITY

#906
US20230190587A1
Human necessities

COSMETIC COMPOSITION COMPRISING SUCROSE ESTER AND LAUROYL LYSINE

#907
US20230190588A1
Human necessities

DISSOLVABLE SOLID FIBROUS SHAMPOO ARTICLES CONTAINING SALTS

#908
US20230190589A1
Human necessities

COSMETIC GEL COMPOSITION COMPRISING PARTICLES

#909
US20230190590A1
Human necessities

LAMELLAR GEL-CONTAINING COMPOSITION, EMULSIFIED COMPOSITION, AND COMPOSITION FOR EXTERNAL-USE SKIN PREPARATION

#910
US20230190591A1
Human necessities

AEROSOL COMPOSITION

#911
US20230190592A1
Human necessities

EMULSIFIABLE PREPARATION, AQUEOUS COSMETIC, FOOD OR BEVERAGE AND PHARMACEUTICAL COMPOSITION

#912 ✅ Patent 12,016,939 granted on 2024-06-25
US20230190593A1
Human necessities

Skin treatment methods and compositions for transdermal delivery of active agents

#913
US20230190594A1
Human necessities

COMPOSITIONS COMPRISING PERSONAL CARE PRODUCTS AND RELATED METHODS

#914 ✅ Patent 12,343,414 granted on 2025-07-01
US20230190595A1
Human necessities

Oral Care Compositions and Methods of Use

#915 ✅ Patent 12,194,121 granted on 2025-01-14
US20230190596A1
Human necessities

Aqueous eyebrow cosmetic and eyebrow cosmetic product

#916 ✅ Patent 12,048,757 granted on 2024-07-30
US20230190597A1
Human necessities

Embossed effect pigment and method of manufacture of embossed effect pigment

#917
US20230190598A1
Human necessities

HAIRSPRAY FORMULATIONS FOR HFO PROPELLANTS

#918
US20230190599A1
Human necessities

A HYDROALCOHOLIC GEL AND A METHOD OF MANUFACTURING SAID GEL

#919
US20230190600A1
Human necessities

COSMETIC COMPOSITION COMPRISING PALMITOYLETHANOLAMIDE FOR SOOTHING EFFECT ON THE SKIN

#920
US20230190601A1
Human necessities

HAIR CONDITIONING COMPOSITION

#921 ✅ Patent 11,975,085 granted on 2024-05-07
US20230190602A1
Human necessities

Non-soap liquid cleanser composition comprising anionic surfactant, caprylic acid, and non-ionic molecule

#922
US20230190603A1
Human necessities

Oral Care Compositions

#923
US20230190604A1
Human necessities

DERMATOLOGIC/PERSONAL CARE CONCENTRATES

#924 ✅ Patent 12,011,495 granted on 2024-06-18
US20230190605A1
Human necessities

Long wear liquid anhydrous composition

#925
US20230190606A1
Human necessities

SULFATE FREE PERSONAL CLEANSING COMPOSITION COMPRISING EFFECTIVE PRESERVATION

#926 ✅ Patent 11,839,677 granted on 2023-12-12
US20230190607A1
Human necessities

Topical antimicrobial composition

#927
US20230190608A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING THE APPEARANCE OF SKIN

#928
US20230190609A1
Human necessities

SELF-TANNING COMPOSITIONS CONTAINING AN AROMATIC SULFONATE AND METHODS THEREOF

#929 ✅ Patent 12,156,929 granted on 2024-12-03
US20230190610A1
Human necessities

Topical antimicrobial composition

#930
US20230190611A1
Human necessities

PERSONAL CARE COMPOSITIONS COMPRISING A METAL PIROCTONE COMPLEX

#931
US20230190612A1
Human necessities

METHODS AND COMPOSITIONS FOR THE PROTECTION OF HAIR

#932
US20230190613A1
Human necessities

SKIN PERFECTING COSMETIC COMPOSITIONS AND METHODS OF USE

#933
US20230190614A1
Human necessities

SELF-TANNING COMPOSITIONS CONTAINING AN ALKYL SULFONATE AND METHODS THEREOF

#934
US20230190615A1
Human necessities

COMPOSITIONS COMPRISING RHAMNOLIPID, ALKYL POLYGLYCOSIDE AND ACYL LACTYLATE

#935
US20230190616A1
Human necessities

COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES

#936
US20230190617A1
Human necessities

COMPOSITIONS AND METHODS RELATING TO PIGMENTATION

#937 ✅ Patent 11,786,450 granted on 2023-10-17
US20230190618A1
Human necessities

Fusion protein comprising heat shock protein 10 and brazzein protein with enhanced anti-oxidation activity and skin cell proliferation effect and anti-wrinkle cosmetic composition comprising the same as effective component

#938
US20230190619A1
Human necessities

COSMETIC COMPOSITION COMPRISING VITAMIN B3 COMPOUND AND LAUROYL LYSINE

#939
US20230190620A1
Human necessities

MOISTURIZER COMPOSITIONS AND METHODS OF MAKING THE SAME

#940
US20230190621A1
Human necessities

WATER-BASED NAIL POLISH

#941
US20230190622A1
Human necessities

METHOD OF MAKING AND USING A SKIN MOISTURIZING FORMULATION

#942
US20230190623A1
Human necessities

COSMETIC NAIL CARE COMPOSITION IN THE FORM OF A VARNISH

#943 ✅ Patent 11,813,349 granted on 2023-11-14
US20230190624A1
Human necessities

Hair colouring compositions in gel or emulsion-gel form

#944
US20230190625A1
Human necessities

PROCESS FOR ALTERING THE COLOR OF KERATIN FIBERS

#945
US20230190626A1
Human necessities

CLEANSER COMPOSITION

#946 ✅ Patent 12,029,807 granted on 2024-07-09
US20230190627A1
Human necessities

No-rinse makeup removal composition

#947
US20230190628A1
Human necessities

SKIN TREATMENT METHOD

#948
US20230190629A1
Human necessities

LONG-WEAR COMPOSITIONS CONTAINING ACID-FUNCTIONAL SILICONE ELASTOMER AND BLOCK COPOLYMER

#949
US20230190630A1
Human necessities

Jet Fuel Wash

#950
US20230190631A1
Human necessities

SKIN CARE COMPOSITIONS

#951
US20230190632A1
Human necessities

Cleansing, Moisturizing and Non-Irritating Topical Compositions

#952
US20230190633A1
Human necessities

A WHEAT BRAN EXTRACT IN A HAIR CARE BLEND

#953 ✅ Patent 11,826,458 granted on 2023-11-28
US20230190634A1
Human necessities

Ginger water composition having ginger extract and method for manufacturing the same

#954
US20230190635A1
Human necessities

PREPARATION METHOD OF A COLLOIDAL SYSTEM OF STABILISATION AND CONTROLLED RELEASE OF ROYAL JELLY COMPONENTS FOR VARIOUS USES

#955
US20230190636A1
Human necessities

METHOD FOR DELIVERY OF BIOLOGIC AGENTS FROM A TOPICAL FORMULATION

#956
US20230190637A9
Human necessities

ANTIBODY AND PROTEIN FORMULATIONS

#957 ✅ Patent 12,239,732 granted on 2025-03-04
US20230190638A1
Human necessities

Anti-CD37 immunoconjugate and anti-CD20 antibody combinations

#958
US20230190639A1
Human necessities

FORMULATIONS OF VASOPRESSIN

#959
US20230190640A1
Human necessities

Devices, Systems, and Methods for Facilitating Tissue Delivery of Drug

#960
US20230190641A1
Human necessities

LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH SUSTAINED RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR THE TREATMENT OF CHRONIC ADRENAL INSUFFICIENCY OR HYPOCORTISOLISM

#961
US20230190642A1
Human necessities

GROWTH FACTOR OTIC FORMULATIONS

#962
US20230190643A1
Human necessities

IMPLANT FOR TREATMENT OF AN OCULAR CONDITION

#963
US20230190644A1
Human necessities

POROUS NANOCOMPOSITE MEDICAL IMPLANT DEVICE

#964
US20230190645A1
Human necessities

COMPOSITION AND METHOD FOR REDUCING ALLERGIC RESPONSE

#965 ✅ Patent 11,712,417 granted on 2023-08-01
US20230190646A1
Human necessities

Fast dispersing suspending composition, method of preparation and application thereof

#966
US20230190647A1
Human necessities

A TOPICAL ANTIBIOTIC CONTAINING PHARMACEUTICAL COMPOSITION FOR BACTERIAL INFECTIONS AND WOUND HEALING

#967
US20230190648A1
Human necessities

Bioactive Tissue Derived Nanocomposite Hydrogels for Permanent Arterial Embolization and Enhanced Vascular Healing

#968
US20230190649A1
Human necessities

LIQUID FORMULATION OF HUMANIZED ANTIBODY FOR TREATING IL-6-MEDIATED DISEASES

#969
US20230190650A1
Human necessities

EUTECTIC BASED ANESTHETIC COMPOSITIONS AND APPLICATIONS THEREOF

#970
US20230190651A1
Human necessities

Topical Aerosol Foams

#971
US20230190652A1
Human necessities

COMPOSITION FOR THE TREATMENT OF COVID-19 AND TREATMENT METHOD

#972
US20230190653A1
Human necessities

METHOD FOR REDUCING OFF-TARGET UPTAKE OR ACCUMULATION OF AGENTS

#973
US20230190654A1
Human necessities

DEXAMETHASONE-LOADED MACROPHAGE-DERIVED MICROVESICLE AS WELL AS PREPARATION METHOD AND APPLICATION THEREOF

#974
US20230190655A1
Human necessities

METHODS FOR CONSOLIDATING ANTIBIOTIC-ELUTING POLYMERIC MATERIALS

#975
US20230190656A1
Human necessities

COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION

#976
US20230190657A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASE

#977
US20230190658A1
Human necessities

MAIN AGENT UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME

#978 ✅ Patent 11,964,054 granted on 2024-04-23
US20230190659A1
Human necessities

Formulations of tegavivint

#979
US20230190660A1
Human necessities

ENCAPSULATED PHARMACEUTICAL COMPOSITIONS, RELATED METHODS OF MAKING, AND RELATED METHODS OF TREATMENT

#980
US20230190661A1
Human necessities

MULTI-COMPONENT PACKAGED DOSAGE FORM AND METHOD

#981
US20230190662A1
Human necessities

Efficacy of a Gastro-Retentive Bile Acid Sequestrant Dosage Form

#982
US20230190663A1
Human necessities

PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF

#983
US20230190664A1
Human necessities

CROSSLINKED PARTICLES

#984
US20230190665A1
Human necessities

THERAPEUTIC PROTEIN-LOADED NANOPARTICLE AND METHOD FOR PREPARING THE SAME

#985
US20230190666A1
Human necessities

A PARTICLE ENCAPSULATING HYDROPHILIC OR AMPHIPHILIC BIOLOGICAL COMPOUNDS

#986 ✅ Patent 12,161,766 granted on 2024-12-10
US20230190667A1
Human necessities

Methods of preparing polyelectrolyte complex nanoparticles

#987
US20230190668A1
Human necessities

SLOW-RELEASE MEDICAL PLASTER

#988
US20230190669A1
Human necessities

DRUG DELIVERY DEVICE INCLUDING PATCH SEGMENTS

#989
US20230190670A1
Human necessities

COMPOSITIONS COMPRISING NOVEL CANNABINOID AND TERPENE PROFILES

#990
US20230190671A1
Human necessities

CANNABIDIOL AND ACTIVE DELIVERY SYSTEMS

#991
US20230190672A1
Human necessities

PHARMACEUTICAL OPHTHALMIC COMPOSITIONS FOR PROTECTION AGAINST BLUE LIGHT

#992
US20230190673A1
Human necessities

USE OF TAPINAROF FOR THE TREATMENT OF ATOPIC DERMATITIS

#993
US20230190674A1
Human necessities

Methods for Reduction of Body Weight with Subcutaneous Formulations

#994
US20230190675A1
Human necessities

VITAMIN A FORMULATION

#995
US20230190676A1
Human necessities

METHODS OF PROTECTING CELLS FROM INSULTS

#996
US20230190677A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AGING-RELATED DISEASES

#997
US20230190678A1
Human necessities

DELAYED RELEASE COMPOSITION COMPRISING ENTERIC COATED DRUG LOADED IN PSYLLIUM HUSK MATRIX

#998 ✅ Patent 12,343,317 granted on 2025-07-01
US20230190679A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS

#999
US20230190680A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING AN RNA VIRUS INDUCED DISEASE

#1000
US20230190681A1
Human necessities

Topical Ointment Composition, Methods Of Use, And Methods Of Preparation

#1001 ✅ Patent 12,370,152 granted on 2025-07-29
US20230190682A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES

#1002
US20230190683A1
Human necessities

METHODS FOR THE TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS

#1003
US20230190684A1
Human necessities

METHODS OF TREATING COVID-19 WITH A NICLOSAMIDE COMPOUND

#1004
US20230190685A1
Human necessities

FORMULATION

#1005
US20230190686A1
Human necessities

COMPOSITION AND METHOD FOR TREATMENT OF DIABETES

#1006
US20230190687A1
Human necessities

SODIUM BUTYRATE FOR USE IN THE PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION

#1007 ✅ Patent 11,969,399 granted on 2024-04-30
US20230190688A1
Human necessities

Compositions and methods for remediating chemical warfare agent exposed skin

#1008
US20230190689A1
Human necessities

METHODS AND COMPOSITIONS FOR INDUCING BROWN ADIPOGENESIS

#1009
US20230190690A1
Human necessities

THERAPEUTIC AND/OR PREVENTIVE AGENT FOR CORONAVIRUS DISEASE 2019 (COVID-19)

#1010
US20230190691A1
Human necessities

APPLICATION OF THYROID HORMONES AND THYROID HORMONE ANALOGUES TO PREPARATION OF DRUGS FOR TREATING SICKLE-CELL DISEASE

#1011 ✅ Patent 12,029,713 granted on 2024-07-09
US20230190692A1
Human necessities

Compositions and methods for the treatment of brain injury

#1012
US20230190693A1
Human necessities

STABLE DIGLYCERIDE EMULSIONS AND METHODS FOR TREATING ORGAN INJURY

#1013
US20230190694A1
Human necessities

COMPOSITIONS FOR AND METHODS OF PRECISION CANCER TREATMENT

#1014
US20230190695A1
Human necessities

TRIBUTYRIN SUPPLEMENTATION PROVIDES BENEFITS FOR MENTAL WELLNESS, IMMUNE HEALTH AND FAT METABOLISM

#1015
US20230190696A1
Human necessities

Pharmaceutical Formulation for Histone Deacetylase Inhibitors

#1016
US20230190697A1
Human necessities

METHODS FOR TREATING VIRAL INFECTIONS WITH NAFAMOSTAT

#1017 ✅ Patent 12,201,603 granted on 2025-01-21
US20230190698A1
Human necessities

Bicyclic compound and use thereof for medical purposes

#1018
US20230190699A1
Human necessities

FORMULATIONS OF DOCETAXEL

#1019
US20230190700A1
Human necessities

THEAFLAVIN COMPOSITION CAPABLE OF PROMOTING WOUND HEALING AS WELL AS PREPARATION METHOD AND USE THEREOF

#1020
US20230190701A1
Human necessities

Compounds for Treating Tauopathies and Restless Leg Syndrome and Methods of Using and Screening for Same

#1021
US20230190702A1
Human necessities

A COMPOSITION FOR IMPROVING QOL OF A 40-YEAR-OLD OR OLDER POSTMENOPAUSAL WOMAN WITHOUT MENOPAUSAL DISORDER

#1022
US20230190703A1
Human necessities

TREATING SAR-COV-2 RELATED HEALTH PROBLEMS

#1023
US20230190704A1
Human necessities

DRUG DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES FUNCTIONALIZED WITH BIOACTIVE COMPOUNDS FROM EUPHORBIA EXTRACT AND THE USES THEREOF

#1024
US20230190705A1
Human necessities

DRUG COMBINATION FOR TREATING DIABETES MELLITUS AND COMPLICATIONS THEREOF AND PHARMACEUTICAL COMPOSITION OF DRUG COMBINATION

#1025 ✅ Patent 12,109,192 granted on 2024-10-08
US20230190706A1
Human necessities

Organic acid addition salts of S-pindolol

#1026
US20230190707A1
Human necessities

COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNOTHERAPY

#1027
US20230190708A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY AND TREATMENT METHOD USING SAME COMPOSITION

#1028
US20230190709A1
Human necessities

METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS

#1029
US20230190710A1
Human necessities

COMPOSITIONS AND METHODS OF REDUCING SERUM CHOLESTEROL AND PCSK9

#1030
US20230190711A1
Human necessities

METHODS FOR TREATING OCULAR DEMODEX USING SPINOSAD FORMULATIONS

#1031
US20230190712A1
Human necessities

PHARMACEUTICAL COMPOSITION

#1032
US20230190713A1
Human necessities

ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF

#1033
US20230190714A1
Human necessities

PRIMARY METHODS AND PROCESSES FOR LIFE EXTENSION IN MODERN-DAY HUMANS

#1034
US20230190715A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF ALBUMIN AND RAPAMYCIN

#1035 ✅ Patent 11,951,098 granted on 2024-04-09
US20230190716A1
Human necessities

Therapeutic agent for meibomian dysfunction

#1036
US20230190717A1
Human necessities

P38 GAMMA INHIBITORS AND METHOD OF USE THEREOF

#1037
US20230190718A1
Human necessities

METHODS FOR THE TREATMENT OF PANCREATITIS AND PREVENTION OF PANCREATIC CANCER

#1038
US20230190719A1
Human necessities

TOPICAL FORMULATIONS OF (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE

#1039 ✅ Patent 12,083,107 granted on 2024-09-10
US20230190720A1
Human necessities

Pharmaceutical compositions comprising glitazones and Nrf2 activators

#1040 ✅ Patent 12,102,625 granted on 2024-10-01
US20230190721A1
Human necessities

Solid forms of FXR agonists

#1041 ✅ Patent 11,903,937 granted on 2024-02-20
US20230190722A1
Human necessities

Anti-androgens for the treatment of metastatic castration-sensitive prostate cancer

#1042
US20230190723A1
Human necessities

METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR TREATING RESPIRATORY DISEASE MEDIATED BY ALPHA-1 ANTITRYPSIN DEFICIENCY

#1043
US20230190724A1
Human necessities

METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH PRIDOPIDINE

#1044
US20230190725A1
Human necessities

MEK INHIBITORS FOR CORNEAL SCARRING AND NEOVASCULARIZATION

#1045
US20230190726A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING NEGATIVE SYMPTOMS IN NON-SCHIZOPHRENIC PATIENTS

#1046
US20230190727A1
Human necessities

METHOD OF TREATMENT OF SCHIZOPHRENIA

#1047
US20230190728A1
Human necessities

NEW THERAPEUTIC USES OF COMPOUNDS

#1048
US20230190729A1
Human necessities

NEW PRODUCT

#1049
US20230190730A1
Human necessities

4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT

#1050
US20230190731A1
Human necessities

FORMULATION COMPRISING HIF PROLYL HYDROXYLASE INHIBITORS

#1051
US20230190732A1
Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE PRODRUG, AND PREPARATION METHOD AND APPLICATION THEREFOR

#1052 ✅ Patent 11,980,615 granted on 2024-05-14
US20230190733A1
Human necessities

Methods and compositions for treating cancer

#1053
US20230190734A1
Human necessities

LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF CORONAVIRUS DISEASE AND SYMPTOMS THEREOF

#1054
US20230190735A1
Human necessities

COMPOSITIONS COMPRISING VORICONAZOLE INHALATION POWDER AND METHODS OF MANUFACTURE AND USE THEREOF

#1055
US20230190736A1
Human necessities

SMALL MOLECULE THERAPEUTICS FOR THE TREATMENT OF VIRAL INFECTIONS

#1056 ✅ Patent 12,097,197 granted on 2024-09-24
US20230190737A1
Human necessities

Stable liquid compositions of netupitant and palonosetron

#1057
US20230190738A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE CONDITIONS

#1058
US20230190739A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA

#1059
US20230190740A1
Human necessities

AN NK-1 RECEPTOR ANTAGONIST FOR TREATING A DISEASE SELECTING FROM SEPSIS, SEPTIC SHOCK, ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) OR MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS)

#1060
US20230190741A1
Human necessities

LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH SUSTAINED RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR THE TREATMENT OF ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA

#1061 ✅ Patent 11,918,578 granted on 2024-03-05
US20230190742A1
Human necessities

Methods for treating cholestasis

#1062
US20230190743A1
Human necessities

TREATMENT WITH ILEAL BILE ACID TRANSPORTER (IBAT) INHIBITORS FOR INCREASED EVENT-FREE SURVIVAL (EFS)

#1063
US20230190744A1
Human necessities

PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBITOR AND A PROGRAMMED DEATH-LIGAND 1 (PD-L1) INHIBITOR AND METHODS OF USE THEREOF

#1064
US20230190745A1
Human necessities

USE OF METABOLIC REGULATORS FOR THE TREATMENT OF COVID-19

#1065
US20230190746A1
Human necessities

METHODS OF TREATING PULMONARY FIBROSIS

#1066
US20230190747A1
Human necessities

PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS

#1067
US20230190748A1
Human necessities

COMPOSITIONS FOR TREATMENT OF AGED DISEASES

#1068
US20230190749A1
Human necessities

TREATMENT OF BRAIN CANCER

#1069
US20230190750A1
Human necessities

METHODS OF TREATING AND PREVENTING CANCER DRUG RESISTANCE

#1070
US20230190751A1
Human necessities

6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors

#1071
US20230190752A1
Human necessities

COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME

#1072
US20230190753A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF A BETA-CATENIN-ASSOCIATED DISEASE OR DISORDER

#1073
US20230190754A1
Human necessities

Therapeutic combinations for the treatment of Progressive Fibrosing interstitial lung diseases

#1074
US20230190755A1
Human necessities

Topical formulations of PI3K-delta inhibitors

#1075
US20230190756A1
Human necessities

PHARMACEUTICAL FORMULATION FOR THE ELIMINATION OF CAUSATIVE AGENTS OF HERPESVIRAL INFECTIONS FROM THE TISSUES OF A MACROORGANISM

#1076 ✅ Patent 11,925,645 granted on 2024-03-12
US20230190757A1
Human necessities

Enhanced caffeinated beverage composition

#1077 ✅ Patent 12,280,060 granted on 2025-04-22
US20230190758A1
Human necessities

Methods of treating cancer using neuronal activity inhibiting agents

#1078
US20230190759A1
Human necessities

LAMOTRIGINE ORAL LIQUID SUSPENSION AND USE THEREOF

#1079
US20230190760A1
Human necessities

ADVANTAGEOUS THERAPIES FOR DISORDERS MEDIATED BY IKAROS OR AIOLOS

#1080
US20230190761A1
Human necessities

METHYLENE BLUE STABILIZED MRNA COMPOSITIONS

#1081
US20230190762A1
Human necessities

STABLE VARENICLINE DOSAGE FORMS

#1082 ✅ Patent 11,992,494 granted on 2024-05-28
US20230190763A1
Human necessities

Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists

#1083
US20230190764A1
Human necessities

Methods and Materials for Treatment of Fibrosis

#1084 ✅ Patent 12,329,761 granted on 2025-06-17
US20230190765A1
Human necessities

METHODS OF USING RHO KINASE INHIBITORS TO TREAT ALZHEIMER'S DISEASE

#1085
US20230190766A1
Human necessities

AGENT FOR TREATING MYOPIA, PREVENTING MYOPIA AND/OR SUPPRESSING MYOPIA PROGRESSION

#1086
US20230190767A1
Human necessities

COMPOSITIONS AND METHODS FOR ENHANCING WNT SIGNALING FOR TREATING CANCER

#1087
US20230190768A1
Human necessities

COMBINATION COMPRISING TRICYCLE COMPOUND AND USE THEREOF IN PREPARATION OF MEDICAMENT FOR TREATING HBV

#1088
US20230190769A1
Human necessities

E PROTEIN CHANNEL BLOCKERS AND ORF3 INHIBITORS AS ANTI-COVID-19 AGENTS

#1089
US20230190770A1
Human necessities

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

#1090 ✅ Patent 12,268,698 granted on 2025-04-08
US20230190771A1
Human necessities

Hybrid polyvinyl alcohol/ linseed dual crosslinked nanocomposite hydrogel loaded with doxycycline for the production of acne patches

#1091
US20230190772A1
Human necessities

PHARMACEUTICAL COMPOSITIONS FOR RELIEF OF COVID-19 SYMPTOMS AND METHODS OF PRODUCING AND USING THEM

#1092
US20230190773A1
Human necessities

INHIBITION OF SLC TRANSPORTER ACTIVITY OR EXPRESSION TO ATTENUATE ANTHRACYCLINE-INDUCED CARDIOTOXICITY

#1093
US20230190774A1
Human necessities

METHOD OF USING SUBSTRATES OF AKR1Bl/AKR1B10 AS ANTI-CANCER DRUGS

#1094 ✅ Patent 12,115,176 granted on 2024-10-15
US20230190775A1
Human necessities

Methods and compositions relating to ClbP inhibition

#1095
US20230190776A1
Human necessities

ENCAPSULATION OF BIOACTIVE INGREDIENTS BY MULTIPLEX EMULSION

#1096
US20230190777A1
Human necessities

MAMMALIAN MILK OLIGOSACCHARIDES PREVENT VIRAL INFECTION OF HUMAN EPITHELIUM

#1097
US20230190778A1
Human necessities

COMPOSITION COMPRISING GLUCOSE OLIGOSACCHARIDE AND PROCESS FOR MAKING THE SAME AND USE THEREOF

#1098
US20230190779A1
Human necessities

Agent for Improving Symptoms of Menopause

#1099
US20230190780A1
Human necessities

METHODS FOR IMMUNOTHERAPY

#1100
US20230190781A1
Human necessities

ADEMETIONINE AND CANNABIDIOL BASED SOLID PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING IT

#1101 ✅ Patent 11,865,132 granted on 2024-01-09
US20230190782A1
Human necessities

Nucleoside derivatives and methods of use thereof

#1102
US20230190783A1
Human necessities

DELIVERY OF LOW VISCOSITY FORMULATIONS

#1103
US20230190784A1
Human necessities

DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY ASSOCIATED WITH IMMUNODEPLETION

#1104
US20230190785A1
Human necessities

COMPOSITIONS AND METHODS FOR SILENCING DNAJC15 GENE EXPRESSION

#1105 ✅ Patent 12,220,427 granted on 2025-02-11
US20230190786A1
Human necessities

Continuous release compositions made from hyaluronic acid, and therapeutic applications of same

#1106
US20230190787A1
Human necessities

SYSTEM AND METHOD FOR TREATING CARDIAC TOXICITY VIA GUT MICROBIOTA

#1107 ✅ Patent 11,931,378 granted on 2024-03-19
US20230190788A1
Human necessities

Method and process to make chitosan-doped strontium oxide nanocomposite for bactericidal applications

#1108 ✅ Patent 11,938,148 granted on 2024-03-26
US20230190789A1
Human necessities

Treatment of neurodegenerative disease with sodium chlorite

#1109 ✅ Patent 12,329,776 granted on 2025-06-17
US20230190790A1
Human necessities

Treatment Methods for ALS Patients

#1110
US20230190791A1
Human necessities

Preparation of a Brain Targeted Artificial Nano-Enzyme and Application

#1111
US20230190792A1
Human necessities

TOPICAL PREPARATIONS

#1112
US20230190793A1
Human necessities

Pharmaceutical Preparation for Use in the Treatment of Systemic Inflammatory Response Syndrome (SIRS)

#1113 ✅ Patent 12,053,488 granted on 2024-08-06
US20230190794A1
Human necessities

Compositions for inhibiting anaerobic microorganisms

#1114 ✅ Patent 11,975,023 granted on 2024-05-07
US20230190795A1
Human necessities

Methods for inhibiting anaerobic microorganisms

#1115
US20230190796A1
Human necessities

ENGINEERED CELLS EXPRESSING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) OR A MODIFIED FORM THEREOF AND RELATED METHODS

#1116
US20230190797A1
Human necessities

COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY

#1117
US20230190798A1
Human necessities

CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL COMPOSITIONS AND METHODS AND USES THEREOF

#1118
US20230190799A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING CEA AND ANTI-CEA-IL2 IMMUNOCYTOKINES FOR CANCER THERAPY

#1119
US20230190800A1
Human necessities

CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE

#1120
US20230190801A1
Human necessities

NATURAL KILLER (NK) CELL COMPOSITIONS AND METHODS FOR GENERATING SAME

#1121
US20230190802A1
Human necessities

METHOD OF TREATMENT OF CANCER OR TUMOUR

#1122
US20230190803A1
Human necessities

METHOD OF TREATMENT OF CANCER OR TUMOUR

#1123
US20230190804A1
Human necessities

COMPOSITIONS AND METHODS FOR AUGMENTING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPIES

#1124
US20230190805A1
Human necessities

METHODS OF IDENTIFYING METASTATIC LESIONS IN A PATIENT AND TREATING THEREOF

#1125
US20230190806A1
Human necessities

METHODS OF TREATING METASTATIC LESIONS AND COMPOSITIONS THEREOF

#1126
US20230190807A1
Human necessities

TCR COMPOUNDS, COMPOSITIONS, AND METHODS OF TREATING

#1127
US20230190808A1
Human necessities

INDICATIONS FOR ANTI-PRAME BINDERS

#1128
US20230190809A1
Human necessities

ALTERNATIVE GENERATION OF ALLOGENEIC HUMAN T CELLS

#1129
US20230190810A1
Human necessities

ANTI-CD33 ANTIBODIES AND USES THEREOF

#1130
US20230190811A1
Human necessities

COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF CANCER

#1131
US20230190812A1
Human necessities

ENGINEERED T CELL RECEPTORS AND METHODS OF USE

#1132
US20230190813A1
Human necessities

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

#1133 ✅ Patent 12,208,137 granted on 2025-01-28
US20230190814A1
Human necessities

Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy

#1134
US20230190815A1
Human necessities

COMPOSITIONS AND METHODS RELATED TO MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES

#1135
US20230190816A1
Human necessities

PHYSICAL FUNCTION RECOVERY PROMOTER

#1136
US20230190817A1
Human necessities

COMPOSITION INCLUDING STEM CELL-DERIVED EXOSOME, AND METHOD FOR PRODUCING SAME

#1137
US20230190818A1
Human necessities

Process for the Manufacturing of Protein-Associated Extracellular Vesicles

#1138
US20230190819A1
Human necessities

COMPOSITIONS AND METHODS CONTAINING EXOSOMES

#1139
US20230190820A1
Human necessities

CELL HARVEST METHOD

#1140
US20230190821A1
Human necessities

REGENERATIVE NONSTEROIDAL ANTI-INFLAMMATORY COMPOSITIONS, METHODS OF PRODUCTION, AND METHODS OF USE THEREOF

#1141
US20230190822A1
Human necessities

METHODS AND COMPOSITIONS FOR ENRICHMENT OF TARGET CELLS

#1142
US20230190823A1
Human necessities

FIBROUS BIRTH TISSUE COMPOSITION AND METHOD OF USE

#1143
US20230190824A1
Human necessities

BACTERIUM OF THE CHRISTENSENELLACEAE FAMILY IN THE PREVENTION AND/OR TREATMENT OF HYPERTRIGLYCERIDEMIA

#1144
US20230190825A1
Human necessities

METHODS AND COMPOSITIONS FOR REDUCING CLOSTRIDIUM DIFFICILE INFECTION

#1145 ✅ Patent 11,944,652 granted on 2024-04-02
US20230190826A1
Human necessities

Nano-vesicles derived from genus bacteria and use thereof

#1146 ✅ Patent 12,036,249 granted on 2024-07-16
US20230190827A1
Human necessities

Anti-bacterial composition against TH1 cell-inducing bacteria

#1147
US20230190828A1
Human necessities

AMMONIA OXIDIZING MICROORGANISMS FOR THE REGULATION OF BLOOD PRESSURE

#1148 ✅ Patent 11,903,980 granted on 2024-02-20
US20230190829A1
Human necessities

Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community

#1149
US20230190830A1
Human necessities

COMPOSITION FOR PREVENTING, IMPROVING OR TREATING BENIGN PROSTATIC HYPERPLASIA OR ALOPECIA, COMPRISING HEAT-KILLED PROBIOTICS AS ACTIVE INGREDIENT

#1150
US20230190831A1
Human necessities

SOLID DOSAGE FORMS WITH IMPROVED DISINTEGRATION PROFILES

#1151 ✅ Patent 12,023,361 granted on 2024-07-02
US20230190832A1
Human necessities

Method for promoting hair growth

#1152
US20230190833A1
Human necessities

BACTERIAL STRAINS, THE COMPOSITIONS THEREOF AND USE THEREOF IN A METHOD FOR THE TREATMENT OF VITAMIN D DEFICIENCY, AND DISORDERS ASSOCIATED THEREWITH

#1153
US20230190834A1
Human necessities

IMMUNOMODULATORY COMPOSITIONS COMPRISING MICROBIAL ENTITIES

#1154
US20230190835A1
Human necessities

PROBIOTIC BACTERIA FOR TREATING ALZHEIMER'S DISEASE

#1155
US20230190836A1
Human necessities

PHOTOSYNTHETICALLY CONTROLLED SPIRULINA EXTRACTS FOR TREATING THE CYTOKINE STORM SYNDROME

#1156
US20230190837A1
Human necessities

GENE THERAPY FOR TREATING FAMILIAL HYPERCHOLESTEROLEMIA

#1157
US20230190838A1
Human necessities

ONCOLYTIC VIRUS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR FOR TREATING TUMORS

#1158
US20230190839A1
Human necessities

COMPOSITIONS AND COMBINATIONS FOR SUBJECTS SUFFERING FROM ENDOMETRIOSIS

#1159 ✅ Patent 12,109,244 granted on 2024-10-08
US20230190840A1
Human necessities

Enteric aerobization therapy

#1160 ✅ Patent 12,005,092 granted on 2024-06-11
US20230190841A1
Human necessities

Herbal composition for breast cancer prevention

#1161 ✅ Patent 11,779,621 granted on 2023-10-10
US20230190842A1
Human necessities

System and method for aerobic respiratory treatment

#1162
US20230190843A1
Human necessities

METHODS FOR ENHANCING SLEEP QUALITY

#1163
US20230190844A1
Human necessities

COMPOSITION AND METHOD FOR TREATING CANCER WITH CANNABINOIDS

#1164 ✅ Patent 12,311,005 granted on 2025-05-27
US20230190845A1
Human necessities

Pharmaceutical compositions and uses thereof in treating Parkinson's disease

#1165 ✅ Patent 12,357,665 granted on 2025-07-15
US20230190846A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND USES THEREOF IN TREATING MUSCLE ATROPHY

#1166
US20230190847A1
Human necessities

PROCESS FOR PREPARING A TOTAL EXTRACT OR A FILTRATE ENABLING THE STABILIZATION OF FRESH PLANT MATTER

#1167
US20230190848A1
Human necessities

P2ET REDUCES COVID SEVERITY BY INHIBITION OF VIRAL REPLICATION, REDUCTION OF PULMONAR FIBROSIS MARKERS AND MODULATION OF INMUNE RESPONSE

#1168
US20230190849A1
Human necessities

USE OF HUANGQI EXTRACT FOR SUPPRESSING SARS-COV-2 ENTRY AND TREATING COVID-19 RELATED CYTOKINE STORM

#1169
US20230190850A1
Human necessities

USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

#1170
US20230190851A1
Human necessities

PLANT COMPOUNDS FOR TREATING ALZHEIMER'S DISEASE

#1171
US20230190852A1
Human necessities

COMPOSITIONS AND METHODS FOR JOINT HEALTH

#1172
US20230190853A1
Human necessities

METHOD FOR DELIPIDATING PLANT EXTRACTS

#1173 ✅ Patent 12,194,074 granted on 2025-01-14
US20230190854A1
Human necessities

Method of reducing muscle damage associated with intensive exercise by administering purple-tea extract

#1174
US20230190855A1
Human necessities

COMPOSITION FOR MAINTAINING OR IMPROVING ORAL IMMUNE FUNCTION

#1175
US20230190856A1
Human necessities

COMPOSITION COMPRISING A COMPLEX COMPRISING A CURCUMINOID COMPOUND, AND STEVIOL GLYCOSIDES OR A LICORICE EXTRACT OR A FRACTION THEREOF, AND USES THEREOF

#1176
US20230190857A1
Human necessities

PEPTIDE WITH AMIDATED CARBOXY TERMINUS HAVING MELANOGENESIS INHIBITORY ACTIVITY AND COMPOSITION COMPRISING SAME

#1177
US20230190858A1
Human necessities

Treatment for Diseases Caused By RNA Viruses

#1178
US20230190859A1
Human necessities

METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH

#1179 ✅ Patent 12,076,365 granted on 2024-09-03
US20230190860A1
Human necessities

CEACAM based antibacterial agents

#1180
US20230190861A1
Human necessities

PEPTIDE THERAPEUTICS FOR ACUTE AND CHRONIC AIRWAY AND ALVEOLAR DISEASES

#1181
US20230190862A1
Human necessities

COMPOSITION FOR PREVENTION, AMELIORATION, OR TREATMENT OF URINATION-RELATED DISEASES COMPRISING CEPHALOTOCIN

#1182
US20230190863A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND ANTI-VIRAL USES THEREOF

#1183
US20230190864A1
Human necessities

PURIFIED AMPHIPHILIC PEPTIDE COMPOSITIONS AND USES THEREOF

#1184
US20230190865A1
Human necessities

VIP Antagonists and Uses in Treating Cancer

#1185
US20230190866A1
Human necessities

PEPTIDE FOR THE TREATMENT OF CYTOKINE STORM SYNDROME

#1186
US20230190867A1
Human necessities

METHODS OF TREATING NASH AND COMPOSITIONS THEREFORE

#1187
US20230190868A1
Human necessities

ISTHMIN 1 FOR TREATMENT OF LUNG INFLAMMATION

#1188
US20230190869A1
Human necessities

PEPTIDE INHIBITORS OF GUANINE NUCLEOTIDE EXCHANGE FACTOR H-1

#1189
US20230190870A1
Human necessities

Method for Treating Lysosomal Storage Diseases with Histatin Peptides

#1190
US20230190871A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTIONS

#1191
US20230190872A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATING DEGENERATIVE BRAIN DISEASE, INCLUDING GLYCINE TRANSPORTER AS ACTIVE INGREDIENT

#1192
US20230190873A1
Human necessities

METHODS AND COMPOSITIONS RELATED TO THE TREATMENT OF NURR1- AND PPARy-MEDIATED CONDITIONS

#1193
US20230190874A1
Human necessities

ANTIGEN BINDING PROTEINS, COMPOSITIONS, AND METHODS OF USING THEREOF

#1194
US20230190875A1
Human necessities

SINGLE-ARM ACTRIIA AND ACTRIIB HETEROMULTIMERS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#1195 ✅ Patent 11,857,601 granted on 2024-01-02
US20230190876A1
Human necessities

Pharmaceutical composition for cancer treatment comprising fusion protein including IL-2 protein and CD80 protein and anticancer drug

#1196 ✅ Patent 11,992,516 granted on 2024-05-28
US20230190877A1
Human necessities

Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies

#1197
US20230190878A1
Human necessities

BETA THYMOSIN PEPTIDES FOR TREATING VIRAL INFECTIONS

#1198
US20230190879A1
Human necessities

DUAL-AGONIST COMPOUND FOR BOTH GLP-1 AND GIP RECEPTORS AND APPLICATION THEREOF

#1199
US20230190880A1
Human necessities

Formulations of Human Parathyroid Hormone (PTH) and Methods for Producing Same

#1200
US20230190881A1
Human necessities

SUBCUTANEOUS ADMINISTRATION OF FACTOR VIII